Objective: To investigate whether glucose-6-phosphate isomerase
(G6PI) antigen and anti-G6PI antibodies could be applied for the clinical
diagnostic markers of rheumatoid arthritis (RA) and its associations with RA
activity states. Methods: The levels of G6PI antigens and anti-G6PI Abs in sera
from 176 RA patients in different states, 35 non-RA patients and 100 healthy
donors and in synovia fluids from 33 patients and 11 non-RA patients were
measured by ELISA. Results: The sensitivity and specificity of G6PI antigens in
the RA patients were 75.0% and 93.3%, respectively. The levels of serum G6PI
antigens in 176 RA patients were significantly higher than non-RA patients and
the health controls. Especially, there was a significant difference between the
active phase and the inactive phase in G6PI antigens levels. The levels of G6PI
antigens in synovia fluid were also significantly higher in RA groups than in
non-RA patients. With the values of the anti-G6PI Abs in sera, there were no
marked differences among RA, non-RA patients and health controls. Also, there
was no significant difference between the active phase and the inactive phase
in RA patients. However, there were no significant differences of G6PI and
anti-G6PI between RA patients and health controls in synovial fluid.
Conclusions: G6PI is highly correlated with the activity states of RA, and
could be applied for a clinical biomarker with high sensitivity and specificity
for the diagnosis of RA.
Cite this paper
Yang, D. , Ge, H. , Dong, J. , Zhu, X. , Sun, G. , Ouyang, W. , Wang, L. and Zhang, G. (2013) The diagnostic significance of glucose-6-phosphate isomerase (G6PI) antigen and anti-G6PI antibody in rheumatoid arthritis patients. Advances in Bioscience and Biotechnology, 4, 818-822. doi: 10.4236/abb.2013.48108.
 Lacotte, S., Brun, S., Muller, S. and Dumortier, H. (2009) CXCR3, inflammation, and autoimmune diseases. Annals of the New York Academy of Sciences, 1173, 310-317.
 Sherer, Y. and Shoenfeld, Y. (2006) Mechanisms of disease: Atherosclerosis in autoimmune diseases. Nature Clinical Practice Rheumatology, 2, 99-106.
 Firestein, G.S. (2003) Evolving concepts of rheumatoid arthritis. Nature, 423, 356-361. doi:10.1038/nature01661
 Gabriel, S.E. and Michaud, K. (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Research & Therapy, 11, 229. doi:10.1186/ar2669
 Matsumoto, I., Staub, A., Banjoist, C. and Mathis D. (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science, 286, 1732-1735.
 Schaller, M., Burton, D.R. and Ditzel, H.J. (2001) Autoantibodies to G6PI in rheumatoid arthritis: Linkage between an animal model and human disease. Nature Immunology, 2, 746-753. doi:10.1038/90696
 Schaller, M., Stohl, W., Tan, S.M., Benoit, V.M., Hilbert, D.M. and Ditzel H.J. (2005) Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis. Annals of the Rheumatic Diseases, 64, 743-749.
 Schaller, M., Stohl, W., Benoit, V., Tan, S.M., Johansen, L. and Ditzel H.J. (2006) Patients with inflammatory arthritic diseases harbor elevated serum and synovial fluid levels of free and immune-complexed glucose-6-phosphate isomerase (G6PI). Biochemical and Biophysical Research Communications, 349, 838-845.
 Fan, L.Y., Zong, M., Wang, Q., Yang, L., Sun, L.S., Ye, Q., Ding, Y.Y. and Ma, J.W. (2010) Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis. Clinica Chimica Acta, 411, 2049-2053.
 Kassahn, D., Kolb, C., Solomon, S., Bochtler, P. and Illges, H. (2002) Few human autoimmune sera detect GPI. Nature Immunology, 3, 411-412.
 Schubert, D., Schmidt, M., Zaiss, D., Jungblut, P.R. and Kamradt, T. (2002) Autoantibodies against GPI and creatine kinase in rheumatoid arthritis. Nature Immunology, 3, 411. doi:10.1038/ni0502-411a
 Herve, C.A., Wait, R. and Venables, P.J. (2003) Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology, 8, 986-988.
 Matsumoto, I., Lee, D.M., Goldbach-Mansky, R., Sumida, T., Hitchon, C.A., Schur, P.H., Anderson, R.J., Coblyn, J.S., Weinblatt, M.E., Brenner, M., Duclos, B., Pasquali, J.L., El-Gabalawy, H., Mathis, D. and Benoist, C. (2003) Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis & Rheumatism, 48, 944-954.
 Klippel, J.H., Crofford, L.J.C., Stone, J.H. and Weyand, C.M. (2001) Primer on the rheumatic diseases. 12th Edition, Arthritis Foundation, Atlanta.
 Kraus, A.P., Langston Jr., M.F. and Lynch, B.L. (1968) Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia. Biochemical and Biophysical Research Communications, 30, 173-177.
 Yu, F.L., Liao, M.H., Lee, J.W. and Shin W.L. (2004) Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3. Biochemical and Biophysical Research Communications, 314, 76-82.